company background image
1931

IVD Medical Holding SEHK:1931 Stock Report

Last Price

HK$2.45

Market Cap

HK$3.3b

7D

-3.2%

1Y

-24.1%

Updated

01 Jul, 2022

Data

Company Financials
1931 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health5/6
Dividends3/6

1931 Stock Overview

IVD Medical Holding Limited, an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally.

IVD Medical Holding Competitors

Price History & Performance

Summary of all time highs, changes and price drops for IVD Medical Holding
Historical stock prices
Current Share PriceHK$2.45
52 Week HighHK$4.28
52 Week LowHK$1.90
Beta0.12
1 Month Change3.38%
3 Month Change-5.04%
1 Year Change-24.15%
3 Year Changen/a
5 Year Changen/a
Change since IPO-20.20%

Recent News & Updates

May 16
IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet

IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Apr 14
IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053

IVD Medical Holding Limited ( HKG:1931 ) will increase its dividend on the 6th of June to HK$0.053, which is 46% higher...

Mar 23
IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding Limited's ( HKG:1931 ) dividend will be increasing on the 6th of June to HK$0.053, with investors...

Shareholder Returns

1931HK HealthcareHK Market
7D-3.2%1.9%1.1%
1Y-24.1%-65.7%-20.9%

Return vs Industry: 1931 exceeded the Hong Kong Healthcare industry which returned -65.7% over the past year.

Return vs Market: 1931 underperformed the Hong Kong Market which returned -20.9% over the past year.

Price Volatility

Is 1931's price volatile compared to industry and market?
1931 volatility
1931 Average Weekly Movement8.4%
Healthcare Industry Average Movement8.3%
Market Average Movement6.9%
10% most volatile stocks in HK Market13.7%
10% least volatile stocks in HK Market3.3%

Stable Share Price: 1931 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: 1931's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1993735Kuk Sing Hohttps://www.ivdholding.com

IVD Medical Holding Limited, an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, Maintenance Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, molecular, microbiology, and point-of-care testing.

IVD Medical Holding Fundamentals Summary

How do IVD Medical Holding's earnings and revenue compare to its market cap?
1931 fundamental statistics
Market CapCN¥2.83b
Earnings (TTM)CN¥174.54m
Revenue (TTM)CN¥2.73b

16.2x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
1931 income statement (TTM)
RevenueCN¥2.73b
Cost of RevenueCN¥2.16b
Gross ProfitCN¥566.27m
Other ExpensesCN¥391.73m
EarningsCN¥174.54m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.13
Gross Margin20.74%
Net Profit Margin6.39%
Debt/Equity Ratio13.7%

How did 1931 perform over the long term?

See historical performance and comparison

Dividends

3.1%

Current Dividend Yield

49%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is 1931 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1931?

Other financial metrics that can be useful for relative valuation.

1931 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.9x
Enterprise Value/EBITDA8.4x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 1931's PE Ratio compare to its peers?

1931 PE Ratio vs Peers
The above table shows the PE ratio for 1931 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average19.3x
6833 Sinco Pharmaceuticals Holdings
18.4xn/aHK$2.9b
1345 China Pioneer Pharma Holdings
19.9xn/aHK$3.3b
2289 Charmacy Pharmaceutical
32.7xn/aHK$885.6m
1099 Sinopharm Group
6.4x10.7%HK$59.4b
1931 IVD Medical Holding
16.2xn/aHK$3.3b

Price-To-Earnings vs Peers: 1931 is good value based on its Price-To-Earnings Ratio (16.2x) compared to the peer average (19.3x).


Price to Earnings Ratio vs Industry

How does 1931's PE Ratio compare vs other companies in the HK Healthcare Industry?

Price-To-Earnings vs Industry: 1931 is good value based on its Price-To-Earnings Ratio (16.2x) compared to the Hong Kong Healthcare industry average (19.2x)


Price to Earnings Ratio vs Fair Ratio

What is 1931's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1931 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio16.2x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 1931's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 1931 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 1931 (HK$2.45) is trading above our estimate of fair value (HK$2.29)

Significantly Below Fair Value: 1931 is trading above our estimate of fair value.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 1931's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is IVD Medical Holding forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


33.6%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as IVD Medical Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Examine IVD Medical Holding's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • IVD Medical Holding competitive advantages and company strategy can generally be found in its financial reports archived here.

Past Performance

How has IVD Medical Holding performed over the past 5 years?

Past Performance Score

3/6

Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


7.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 1931 has high quality earnings.

Growing Profit Margin: 1931's current net profit margins (6.4%) are lower than last year (6.5%).


Past Earnings Growth Analysis

Earnings Trend: 1931's earnings have grown by 7% per year over the past 5 years.

Accelerating Growth: 1931's earnings growth over the past year (10%) exceeds its 5-year average (7% per year).

Earnings vs Industry: 1931 earnings growth over the past year (10%) underperformed the Healthcare industry 23.9%.


Return on Equity

High ROE: 1931's Return on Equity (5.4%) is considered low.


Discover strong past performing companies

Financial Health

How is IVD Medical Holding's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 1931's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥1.2B).

Long Term Liabilities: 1931's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥218.1M).


Debt to Equity History and Analysis

Debt Level: 1931 has more cash than its total debt.

Reducing Debt: 1931's debt to equity ratio has increased from 1.3% to 13.7% over the past 5 years.

Debt Coverage: 1931's debt is well covered by operating cash flow (39.9%).

Interest Coverage: 1931's interest payments on its debt are well covered by EBIT (13.9x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is IVD Medical Holding current dividend yield, its reliability and sustainability?

Dividend Score

2/6

Dividend Score 2/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


3.08%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 1931's dividend (3.08%) is higher than the bottom 25% of dividend payers in the Hong Kong market (2.73%).

High Dividend: 1931's dividend (3.08%) is low compared to the top 25% of dividend payers in the Hong Kong market (7.83%).


Stability and Growth of Payments

Stable Dividend: 1931 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 1931's dividend payments have increased, but the company has only paid a dividend for 2 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (49.1%), 1931's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonable cash payout ratio (63.4%), 1931's dividend payments are covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

3.0yrs

Average management tenure


CEO

Kuk Sing Ho (63 yo)

3yrs

Tenure

Mr. Ho Kuk Sing serves as Executive Director, Chairman of the Board and Chief Executive Officer at IVD Medical Holding Limited since June 21, 2019. He was Director of IVD Medical Holding Limited since May...


Leadership Team

Experienced Management: 1931's management team is considered experienced (3 years average tenure).


Board Members

Experienced Board: 1931's board of directors are considered experienced (3.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

IVD Medical Holding Limited's employee growth, exchange listings and data sources


Key Information

  • Name: IVD Medical Holding Limited
  • Ticker: 1931
  • Exchange: SEHK
  • Founded: 1993
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Implied Market Cap: HK$3.319b
  • Shares outstanding: 1.35b
  • Website: https://www.ivdholding.com

Number of Employees


Location

  • IVD Medical Holding Limited
  • Building 6
  • Room 602, Lane 299
  • Shanghai
  • China

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/07/01 00:00
End of Day Share Price2022/06/30 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.